Which Weight Management Treatment Suits Your Needs?
Wegovy vs Mounjaro vs Ozempic: Understanding the Key Differences
When comparing Wegovy vs Mounjaro vs Ozempic, the fundamental distinction lies in their licensed indications and mechanisms of action. Wegovy (semaglutide) and Mounjaro (tirzepatide) are both licensed for weight management in adults with obesity or overweight with comorbidities, whilst Ozempic remains licensed exclusively for type 2 diabetes treatment. Wegovy works as a GLP-1 receptor agonist, mimicking natural hormones that regulate appetite and food intake. Mounjaro operates as a dual GIP and GLP-1 receptor agonist, targeting two hormone pathways simultaneously to support weight management alongside a reduced-calorie diet and increased physical activity.
The dosing schedules for Wegovy vs Mounjaro also differ significantly in their escalation patterns. Wegovy follows a structured five-dose escalation from 0.25mg to 2.4mg maintenance over 16 weeks, whilst Mounjaro progresses through six doses from 2.5mg to 15mg. Both prescription-only medicines require clinical assessment to determine suitability, with EverydayMeds providing comprehensive prescriber review for both options. Understanding these mechanistic differences helps inform discussions with your prescriber about which treatment approach may align best with your individual weight management goals.
Pricing Comparison: Wegovy vs Mounjaro Cost Analysis
EverydayMeds provides transparent pricing for both Wegovy and Mounjaro options, with Wegovy starter doses beginning at £79.99 for the 0.25mg pen. The complete Wegovy escalation includes 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99 per pen. Our Getting Started bundles offer convenient multi-dose packages, such as the Intro Duo (0.25mg and 0.5mg) for £169.99, providing two months of initial treatment. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices.
Mounjaro pricing follows a similar structure with doses escalating from 2.5mg through to 15mg maintenance. Both treatments represent significant investment in long-term weight management, with bundle options providing convenience and Reliable Supply continuity. The Ultimate Stability Trio for Wegovy offers three months of 2.4mg maintenance supply for £649.99, ensuring consistent access to your prescribed dose. When evaluating Wegovy vs Mounjaro costs, consider both the individual dose pricing and the duration required at each escalation level for accurate budget planning.
Clinical Evidence: Wegovy vs Mounjaro Research Findings
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes. STEP 1 showed approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 5 maintained 15.2% weight reduction at two years (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further revealed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, demonstrating the dual GIP and GLP-1 mechanism's effectiveness in weight management settings. Both treatments require ongoing commitment alongside lifestyle modifications, with weight regain observed when treatment discontinues. Clinical trials suggest that approximately two-thirds of weight lost may return within one year of stopping treatment, emphasising the long-term nature of weight management interventions.
How Wegovy Works in Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone produced in the intestines. This mechanism targets the brain's appetite control centres, particularly the hypothalamus, to reduce hunger signals and promote feelings of fullness after smaller meals. The medication may also slow gastric emptying, contributing to prolonged satiety and reduced food intake throughout the day. Weekly injection timing helps maintain consistent semaglutide levels, supporting appetite regulation over seven-day periods. Clinical studies suggest that Wegovy may reduce food cravings, particularly for high-calorie foods, though individual responses vary considerably. The FlexTouch pen delivery system ensures accurate dosing whilst the once-weekly schedule supports treatment adherence for long-term weight management success.
EverydayMeds Ordering Process for Wegovy and Mounjaro
Our streamlined ordering process begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review each application within standard 3 working days, with express 24-hour review available for urgent requirements. Once approved, both Wegovy and Mounjaro are dispatched via next-day delivery using specialised cold-chain packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all prescription-only medicines meet strict quality standards from manufacturer to delivery. Temperature-controlled logistics protect medication efficacy throughout transit, with tracking provided for delivery monitoring. Customer support remains available throughout the treatment journey, providing guidance on injection technique, dose escalation, and potential side effect management.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers significant storage advantages over Mounjaro, remaining stable at room temperature below 30°C for up to 6 weeks once removed from refrigeration. This extended room temperature stability supports travel and lifestyle flexibility compared to Mounjaro's 21-day room temperature limit. Prior to first use, both medications require refrigeration between 2-8°C to maintain pharmaceutical integrity. The FlexTouch pen system used for Wegovy provides intuitive dose selection with audible clicks confirming accurate dosing, whilst the clear medication window allows visual inspection before injection. Dose escalation protocols cannot be accelerated, with minimum 4-week intervals required between increases to minimise gastrointestinal side effects. Proper storage and handling ensure optimal medication effectiveness throughout the complete treatment course from initiation through maintenance dosing.
Wegovy vs Mounjaro: Choosing Between Single and Dual Hormone Approaches
The choice between Wegovy's single GLP-1 mechanism and Mounjaro's dual GIP/GLP-1 approach depends on individual clinical factors and prescriber assessment. Wegovy's established semaglutide platform offers extensive real-world experience with well-documented safety profiles and predictable dose escalation patterns. The medication's cardiovascular outcome data provides additional confidence for patients with existing heart disease risk factors.
Mounjaro's dual hormone approach targets both GLP-1 and GIP pathways, potentially offering different mechanistic advantages for certain patient populations. However, both treatments require identical lifestyle commitments including reduced-calorie diet and increased physical activity for optimal effectiveness. Your prescriber can evaluate medical history, concurrent medications, and individual risk factors to determine which approach may offer the most suitable risk-benefit profile for your specific circumstances.
Complete Treatment Support from EverydayMeds
EverydayMeds provides comprehensive support for both Wegovy and Mounjaro patients throughout their weight management journey. Our clinical team offers guidance on injection techniques, dose escalation timing, and lifestyle modification strategies to optimise treatment outcomes. Both treatments are available with flexible ordering options including individual pens, convenient bundles, and maintenance supply packages to prevent treatment interruptions. New customers can access their initial prescription using discount code FIRST40, whilst returning customers benefit from DOSE25 savings at checkout. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which option may be most suitable for your weight management goals. Both Wegovy and Mounjaro represent significant advances in prescription weight management support when used alongside comprehensive lifestyle modifications under proper medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
